SCHEMBL22280698

SCHEMBL22280698

Cc1cc(C)c(-c2ccc3c4ccc(Oc5ccc6c7ccc(-c8c(C)cc(C)cc8C)cc7n7c8ccccc8nc7c6c5)cc4c4nc5ccccc5n4c3c2)c(C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.42
HPGD P15428 8/20 0.42
KDM4E B2RXH2 8/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 5/20 0.40
LMNA P02545 3/20 0.40
TP53 P04637 3/20 0.40
POLB P06746 2/20 0.40
HSD17B10 Q99714 2/20 0.40
GAA P10253 2/20 0.39
GLA P06280 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HTT P42858 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
PDE2A O00408 1/20 0.37
PDE10A Q9Y233 1/20 0.37
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
CASP1 P29466 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22280937 0.94 KDM4E (0.41) ALDH1A1HPGDKDM4ESMN1; SMN2KMT2A
SCHEMBL22280695 0.93 KDM4E (0.40) ALDH1A1HPGDKDM4ESMN1; SMN2KMT2A
SCHEMBL22281100 0.92 PDE2A (0.43) ALDH1A1HPGDKDM4ESMN1; SMN2KMT2A
SCHEMBL22281195 0.91 ALDH1A1 (0.38) ALDH1A1HPGDKDM4ESMN1; SMN2KMT2A
SCHEMBL22280701 0.87 ALDH1A1 (0.39) ALDH1A1HPGDKDM4ESMN1; SMN2KMT2A
SCHEMBL22280699 0.87 PDE2A (0.42) ALDH1A1HPGDKDM4ESMN1; SMN2KMT2A
SCHEMBL22280938 0.86 PDE2A (0.43) ALDH1A1HPGDKDM4ESMN1; SMN2KMT2A
SCHEMBL22280914 0.85 MAPT (0.37) ALDH1A1HPGDKDM4ESMN1; SMN2KMT2A
SCHEMBL22281210 0.84 KDM4E (0.41) ALDH1A1HPGDKDM4ESMN1; SMN2KMT2A
SCHEMBL22280944 0.83 KDM4E (0.41) ALDH1A1HPGDKDM4ESMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200239505-A1 BLUE PHOSPHORESCENT EMITTERS EMPLOYING FUNCTIONALIZED IMIDAZOPHENTHRIDINE AND ANALOGUES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2020-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200239505-A1 BLUE PHOSPHORESCENT EMITTERS EMPLOYING FUNCTIONALIZED IMIDAZOPHENTHRIDINE AND ANALOGUES EML4, TYR, TYMP ALDH1A1 2652/4885HPGD 4780/4885KDM4E 1356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.